Wed, 10 Jan 2024 | BUSINESS SALE
GBUK Group Limited, a Yorkshire medical device manufacturer, has been acquired by private equity firm A&M Capital Europe LLP (AMCE). The deal sees AMCE, a middle market private equity firm based in London with around €650 million of assets under management (AUM), acquire H2 Equity Partners’ holding in GBUK.
GBUK is based in Selby and provides acute medical care device for the critical care, vascular, enteral and patient handling sectors. The firm’s devices are used by healthcare professionals to treat patients in more than 45 countries worldwide and the company continually uses its capabilities in research and development (R&D) and product development to expand its range of products.
H2 Equity Partners acquired a majority stake in the company from its founders in 2015 and, since then, have worked alongside its management team to support the business’ continuing growth and development.
Since its acquisition by H2, the group has evolved into an own-product focused business, with an international reach and an extensive portfolio of devices. The company has completed four acquisitions over the past eight years and seen sales more than quadruple to £80 million per year.
GBUK’s partnership with AMCE is expected to help the group further enhance its patient care services and drive the necessary innovation for the firm to support the constantly evolving and changing needs of healthcare providers and patients.
M&A in the medical technology (MedTech) sector remained resilient last year, despite a dramatic overall drop in activity. Heading into 2024, optimism is high that dealmaking in the sector can grow, with innovation and increased private equity interest forecast to be key drivers of M&A activity - Find out more in this exclusive, in-depth analysis of dealmaking in the MedTech sector.
Find out more about how companies can secure private equity backing for their growth strategies.
This is an exciting opportunity to acquire a well-established community pharmacy in Cambridgeshire that has been independently operating for over 20 years with a 40-hour contract.
LEASEHOLD
This well-established and modern pharmacy in the West Midlands boasts over two decades of success and a strategic location with potential to enhance OTC and services revenue.
This long-established Cardiff pharmacy is experiencing consistent turnover growth, benefiting from a 5% NHS funding increase in Wales.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.